(Q46497112)

22 December 2017

title

Penetration of ertapenem into different pulmonary compartments of patients undergoing lung surgery (English)

1 reference

22 December 2017

7

Tobias Welte

1 reference

22 December 2017

6

Hartmut Derendorf

1 reference

22 December 2017

author name string

Olaf Burkhardt

1

1 reference

22 December 2017

Jolanta Majcher-Peszynska

2

1 reference

22 December 2017

Klaus Borner

3

1 reference

22 December 2017

Ralf Mundkowski

4

1 reference

22 December 2017

Bernd Drewelow

5

1 reference

22 December 2017

publication date

1 June 2005

1 reference

22 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

22 December 2017

volume

45

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

659-665

1 reference

22 December 2017

Ertapenem, the first of a new group of carbapenems

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

Properties and potential of ertapenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

In vitro activity of ertapenem (MK-0826) against multi-drug resistant Streptococcus pneumoniae compared with 13 other antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

Pharmacokinetics of ertapenem in healthy young volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

Pharmacokinetics of total and unbound ertapenem in healthy elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

Tissue penetration by ertapenem, a parenteral carbapenem administered once daily, in suction-induced skin blister fluid in healthy young volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

Tissue distribution of imipenem in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

Predicting the efficacy of antimicrobial agents in respiratory infections--is tissue concentration a valid measure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

Therapeutic efficacy of cefadroxil and cephalexin for pneumonia in a rat test model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

Pharmacokinetics of four fluoroquinolones in an animal model of infected lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

Pharmacokinetics and tissue penetration of a single dose of ceftriaxone (1,000 milligrams intravenously) for antibiotic prophylaxis in thoracic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

Comparative pharmacokinetics of the carbapenems: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276117

21 January 2018

Identifiers

DOI

10.1177/0091270005276117

1 reference

22 December 2017

1 reference

22 December 2017